Satori Pharmaceuticals' Series C Round

Satori Pharmaceuticals raised a round of funding on February 23, 2012.

Satori Pharmaceuticals is a developing therapeutics for Alzheimer's Disease (AD). The company is developing small molecule compounds that are orally active and designed for chronic dosing in seniors. …

Articles about Satori Pharmaceuticals' Series C Round: